AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

$19.45
-0.50 (-2.51%)
As of Nov 5, 9:55 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +494.0% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $19.45
Current
$19.45
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
236.4%
Low target
Base Case
$115.54
+494.0%
Avg target
Bull Case
$156.42
+704.2%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$21.68
-10.3% from high
52-Week Low
$9.99
+94.7% from low
50-Day SMA
$19.26
+1.0% vs SMA
200-Day SMA
$15.85
+22.7% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+433.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%